Meeting of the National Biodefense Science Board, 62634-62635 [2013-24620]
Download as PDF
62634
Federal Register / Vol. 78, No. 204 / Tuesday, October 22, 2013 / Notices
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than November 15,
2013.
A. Federal Reserve Bank of San
Francisco (Gerald C. Tsai, Director,
Applications and Enforcement) 101
Market Street, San Francisco, California
94105–1579:
1. TFB Bancorp, Inc., Yuma, Arizona;
to become a bank holding company by
acquiring 100 percent of the voting
shares of The Foothills Bank, Yuma,
Arizona.
Board of Governors of the Federal Reserve
System, October 17, 2013.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
the assets or the ownership of, control
of, or the power to vote shares of a
savings association and nonbanking
companies owned by the savings and
loan holding company, including the
companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the HOLA (12 U.S.C. 1467a(e)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 10(c)(4)(B) of the
HOLA (12 U.S.C. 1467a(c)(4)(B)). Unless
otherwise noted, nonbanking activities
will be conducted throughout the
United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than November 15,
2013.
A. Federal Reserve Bank of Dallas (E.
Ann Worthy, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. Grant Scott as Trustee of the Voting
Trust Agreement dated as of December
6, 2012, Raleigh, North Carolina; to
become a savings and loan holding
company through controlling NexBank
Capital, Inc., and thereby indirectly
acquiring voting shares of NexBank,
State Savings Bank, both in Dallas,
Texas.
Board of Governors of the Federal Reserve
System, October 17, 2013.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2013–24618 Filed 10–21–13; 8:45 am]
BILLING CODE 6210–01–P
[FR Doc. 2013–24617 Filed 10–21–13; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
FEDERAL RESERVE SYSTEM
sroberts on DSK5SPTVN1PROD with FRONT MATTER
Formations of, Acquisitions by, and
Mergers of Savings and Loan Holding
Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Home Owners’ Loan Act
(12 U.S.C. 1461 et seq.) (HOLA),
Regulation LL (12 CFR part 238), and
Regulation MM (12 CFR part 239), and
all other applicable statutes and
regulations to become a savings and
loan holding company and/or to acquire
VerDate Mar<15>2010
21:08 Oct 21, 2013
Jkt 232001
Meeting of the National Biodefense
Science Board
Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (HHS) is hereby giving notice
that the National Biodefense Science
Board (NBSB) will be holding a public
SUMMARY:
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
meeting via teleconference. The meeting
is open to the public.
DATES: The NBSB will hold a public
meeting on October 31, 2013,
tentatively, from 3:00 p.m. to 4:00 p.m.
ET. The agenda is subject to change as
priorities dictate.
ADDRESSES: Individuals who wish to
participate should send an email to
NBSB@HHS.GOV with ‘‘NBSB
Registration’’ in the subject line. The
meeting will occur by teleconference.
To attend via teleconference and for
further instructions, please visit the
NBSB Web site at WWW.PHE.GOV/
NBSB.
FOR FURTHER INFORMATION CONTACT: The
National Biodefense Science Board
mailbox: NBSB@HHS.GOV.
SUPPLEMENTARY INFORMATION: Pursuant
to section 319M of the Public Health
Service Act (42 U.S.C. 247d–7f) and
section 222 of the Public Health Service
Act (42 U.S.C. 217a), the Department of
Health and Human Services established
the National Biodefense Science Board.
The NBSB shall provide expert advice
and guidance to the Secretary on
scientific, technical, and other matters
of special interest to HHS regarding
current and future chemical, biological,
nuclear, and radiological agents,
whether naturally occurring, accidental,
or deliberate. The NBSB may also
provide advice and guidance to the
Secretary and/or the Assistant Secretary
for Preparedness and Response (ASPR)
on other matters related to public health
emergency preparedness and response.
Background: This public meeting via
teleconference will be dedicated to the
NBSB’s deliberation and vote on the
findings from the NBSB’s Situational
Awareness Working Group, and the
NBSB’s National Health Security
Working Group. Subsequent agenda
topics will be added as priorities
dictate. Any additional agenda topics
will be available on the NBSB’s October
31, 2013, meeting Web page, available at
WWW.PHE.GOV/NBSB.
Availability of Materials: The meeting
agenda and materials will be posted
prior to the meeting on the October
meeting Web page at WWW.PHE.GOV/
NBSB.
Procedures for Providing Public Input:
Members of the public are invited to
attend by teleconference via a toll-free
call-in phone number which is available
on the NBSB Web site at
WWW.PHE.GOV/NBSB. All members of
the public are encouraged to provide
written comment to the NBSB. All
written comments must be received
prior to October 31, 2013, and should be
sent by email to NBSB@HHS.GOV with
‘‘NBSB Public Comment’’ as the subject
E:\FR\FM\22OCN1.SGM
22OCN1
Federal Register / Vol. 78, No. 204 / Tuesday, October 22, 2013 / Notices
line. Public comments received by close
of business one week prior to each
teleconference will be distributed to the
NBSB in advance.
Dated: September 30, 2013.
Nicole Lurie,
Assistant Secretary for Preparedness and
Response.
[FR Doc. 2013–24620 Filed 10–21–13; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee on Procedures Review,
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
sroberts on DSK5SPTVN1PROD with FRONT MATTER
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 11:00 a.m.–5:00 p.m.
Eastern Time, November 7, 2013.
Place: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1 (866) 659–0537 and the pass
code is 9933701.
Status: Open to the public, but without a
public comment period. The instructions for
the submission of written comments are
provided in the section entitled ‘‘MATTERS
TO BE DISCUSSED.’’ To access by
conference call dial the following
information 1 (866) 659–0537, Participant
Pass Code 9933701.
Background: The ABRWH was established
under the Energy Employees Occupational
Illness Compensation Program Act of 2000 to
advise the President on a variety of policy
and technical functions required to
implement and effectively manage the
compensation program. Key functions of the
ABRWH include providing advice on the
development of probability of causation
guidelines that have been promulgated by the
Department of Health and Human Services
(HHS) as a final rule; advice on methods of
dose reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the ABRWH to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2015.
VerDate Mar<15>2010
21:08 Oct 21, 2013
Jkt 232001
Purpose: The ABRWH is charged with (a)
providing advice to the Secretary, HHS, on
the development of guidelines under
Executive Order 13179; (b) providing advice
to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction
efforts performed for this program; and (c)
upon request by the Secretary, HHS, advising
the Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is a
reasonable likelihood that such radiation
doses may have endangered the health of
members of this class. The Subcommittee on
Procedures Review was established to aid the
ABRWH in carrying out its duty to advise the
Secretary, HHS, on dose reconstructions. The
Subcommittee on Procedures Review is
responsible for overseeing, tracking, and
participating in the reviews of all procedures
used in the dose reconstruction process by
the NIOSH Division of Compensation
Analysis and Support (DCAS) and its dose
reconstruction contractor (Oak Ridge
Associated Universities—ORAU).
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes
discussion of the following ORAU and DCAS
procedures: ORAU Team Technical
Information Bulletin (OTIB) 054 (‘‘Fission
and Activation Product Assignment for
Internal Dose-Related Gross Beta and Gross
Gamma Analyses’’), Program Evaluation
Report (PER) 011 (‘‘K–25 TBD and TIB
Revisions’’), PER 014 (‘‘Construction Trades
Workers’’), PER 020 (‘‘Blockson TBD
Revision’’), PER 25 (‘‘Huntington Pilot Plant
TBD Revision’’), PER 030 (‘‘Savannah River
Site TBD Revisions’’), PER 031 (‘‘Y–12 TBD
Revisions’’), PER 033 (‘‘Reduction Pilot Plant
TBD Revision’’), PER 038 (‘‘Hooker
Electrochemical TBD Revisions’’); Update on
Review of ORAU Team Report 0053
(‘‘Stratified Co-Worker Sets); estimating
radiation doses associated with localized
skin exposures to uranium at Atomic
Weapons Employer facilities; International
Commission on Radiological Protection
Publication 116 (‘‘Conversion Coefficients for
Radiological Protection Quantities for
External Radiation Exposures’’); and a
continuation of the comment-resolution
process for other dose reconstruction
procedures under review by the
Subcommittee.
The agenda is subject to change as
priorities dictate.
This meeting is open to the public, but
without a public comment period. In the
event an individual wishes to provide
comments, written comments may be
submitted. Any written comments received
will be provided at the meeting and should
be submitted to the contact person below in
advance of the meeting.
Contact Person for More Information:
Theodore Katz, Designated Federal Official,
NIOSH, CDC, 1600 Clifton Road, Mailstop
E–20, Atlanta GA 30333, Telephone (513)
533–6800, Toll Free 1 (800) CDC–INFO,
Email dcas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
62635
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–24339 Filed 10–21–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 9:00 a.m.–3:15 p.m. EDT,
October 28, 2013.
Place: CDC, Building 21, Room 1204A,
1600 Clifton Road NE., Atlanta, Georgia
30333.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 20 people. The
public is welcome to participate during the
public comment, which is tentatively
scheduled from 3:00 to 3:10 p.m. This
meeting is also available by teleconference.
Please dial (877) 496–4855 and enter code
4363556.
Purpose: The Subcommittee will provide
advice to the CDC Director through the ACD
on strategic and other health disparities and
health equity issues and provide guidance on
opportunities for CDC.
Matters To Be Discussed: The Health
Disparities Subcommittee members will
discuss some of the current health equity
activities at CDC, as well as discuss health
equity recommendations to the CDC ACD.
The agenda is subject to change as
priorities dictate.
Web links: Connection-1: https://
wm.onlinevideoservice.com/CDC1.
Mac/Flash Connection-3: https://
www.onlinevideoservice.com/clients/CDC/
?mount=CDC3.
Closed Caption is only available on the
Windows Media link Connection-1. Viewer’s
report is given the next day. Number for
Technical Support: (404) 639–3737.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600 Clifton
Road NE., M/S K–77, Atlanta, Georgia 30333
Telephone (770) 488–8200, Email: LEL1@
cdc.gov.
E:\FR\FM\22OCN1.SGM
22OCN1
Agencies
[Federal Register Volume 78, Number 204 (Tuesday, October 22, 2013)]
[Notices]
[Pages 62634-62635]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24620]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Biodefense Science Board
AGENCY: Office of the Secretary, Department of Health and Human
Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services (HHS) is hereby giving notice
that the National Biodefense Science Board (NBSB) will be holding a
public meeting via teleconference. The meeting is open to the public.
DATES: The NBSB will hold a public meeting on October 31, 2013,
tentatively, from 3:00 p.m. to 4:00 p.m. ET. The agenda is subject to
change as priorities dictate.
ADDRESSES: Individuals who wish to participate should send an email to
NBSB@HHS.GOV with ``NBSB Registration'' in the subject line. The
meeting will occur by teleconference. To attend via teleconference and
for further instructions, please visit the NBSB Web site at
WWW.PHE.GOV/NBSB.
FOR FURTHER INFORMATION CONTACT: The National Biodefense Science Board
mailbox: NBSB@HHS.GOV.
SUPPLEMENTARY INFORMATION: Pursuant to section 319M of the Public
Health Service Act (42 U.S.C. 247d-7f) and section 222 of the Public
Health Service Act (42 U.S.C. 217a), the Department of Health and Human
Services established the National Biodefense Science Board. The NBSB
shall provide expert advice and guidance to the Secretary on
scientific, technical, and other matters of special interest to HHS
regarding current and future chemical, biological, nuclear, and
radiological agents, whether naturally occurring, accidental, or
deliberate. The NBSB may also provide advice and guidance to the
Secretary and/or the Assistant Secretary for Preparedness and Response
(ASPR) on other matters related to public health emergency preparedness
and response.
Background: This public meeting via teleconference will be
dedicated to the NBSB's deliberation and vote on the findings from the
NBSB's Situational Awareness Working Group, and the NBSB's National
Health Security Working Group. Subsequent agenda topics will be added
as priorities dictate. Any additional agenda topics will be available
on the NBSB's October 31, 2013, meeting Web page, available at
WWW.PHE.GOV/NBSB.
Availability of Materials: The meeting agenda and materials will be
posted prior to the meeting on the October meeting Web page at
WWW.PHE.GOV/NBSB.
Procedures for Providing Public Input: Members of the public are
invited to attend by teleconference via a toll-free call-in phone
number which is available on the NBSB Web site at WWW.PHE.GOV/NBSB. All
members of the public are encouraged to provide written comment to the
NBSB. All written comments must be received prior to October 31, 2013,
and should be sent by email to NBSB@HHS.GOV with ``NBSB Public
Comment'' as the subject
[[Page 62635]]
line. Public comments received by close of business one week prior to
each teleconference will be distributed to the NBSB in advance.
Dated: September 30, 2013.
Nicole Lurie,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2013-24620 Filed 10-21-13; 8:45 am]
BILLING CODE 4150-28-P